Careful design and maintenance of our fragment library is of great importance to the ZoBio lead discovery process. Continuous improvement of our collection relies both on commercial acquisition of new fragments and gaining access to unique and novel compounds…
ICMRBS Webinar Series
Online Marta Carneiro, Head of Structural Biology at ZoBio, presented the lecture ‘NMR in target driven drug discovery: why not?’ on Wednesday 25 November 2020. Marta has discussed several examples of how ZoBio uses NMR in various ways to streamline the discovery process and reduce downstream attrition. This talk was a part of the Drug…
The ZoBio Fragment Library: Chemically Diverse Starting Points for Drug Discovery
ZoBio strives to provide attractive, validated chemical starting points for your drug discovery projects. To achieve this goal, we have been building and maintaining the ZoBio fragment library since 2003. Our fragment library has been screened against more than 100 targets…
NMR in Target Driven Drug Discovery: Why Not?
NMR is a powerful and information rich tool that can provide critical information at many stages of the pre-clinical drug discovery process.
In a recent publication ZoBio scientists discuss a number of examples…